Literature DB >> 19805546

Amyotrophic lateral sclerosis-linked mutant SOD1 sequesters Hu antigen R (HuR) and TIA-1-related protein (TIAR): implications for impaired post-transcriptional regulation of vascular endothelial growth factor.

Liang Lu1, Shuying Wang, Lei Zheng, Xuelin Li, Esther A Suswam, Xiaowen Zhang, Crystal G Wheeler, L B Nabors, Natalia Filippova, Peter H King.   

Abstract

Down-regulation of vascular endothelial growth factor (VEGF) in the mouse leads to progressive and selective degeneration of motor neurons similar to amyotrophic lateral sclerosis (ALS). In mice expressing ALS-associated mutant superoxide dismutase 1 (SOD1), VEGF mRNA expression in the spinal cord declines significantly prior to the onset of clinical manifestations. In vitro models suggest that dysregulation of VEGF mRNA stability contributes to that decline. Here, we show that the major RNA stabilizer, Hu Antigen R (HuR), and TIA-1-related protein (TIAR) colocalize with mutant SOD1 in mouse spinal cord extracts and cultured glioma cells. The colocalization was markedly reduced or abolished by RNase treatment. Immunoanalysis of transfected cells indicated that colocalization occurred in insoluble aggregates and inclusions. RNA immunoprecipitation showed a significant loss of VEGF mRNA binding to HuR and TIAR in mutant SOD1 cells, and there was marked depletion of HuR from polysomes. Ectopic expression of HuR in mutant SOD1 cells more than doubled the mRNA half-life of VEGF and significantly increased expression to that of wild-type SOD1 control. Cellular effects produced by mutant SOD1, including impaired mitochondrial function and oxidative stress-induced apoptosis, were reversed by HuR in a gene dose-dependent pattern. In summary, our findings indicate that mutant SOD1 impairs post-transcriptional regulation by sequestering key regulatory RNA-binding proteins. The rescue effect of HuR suggests that this impairment, whether related to VEGF or other potential mRNA targets, contributes to cytotoxicity in ALS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19805546      PMCID: PMC2797169          DOI: 10.1074/jbc.M109.067918

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Analysis of turnover and translation regulatory RNA-binding protein expression through binding to cognate mRNAs.

Authors:  Rudolf Pullmann; Hyeon Ho Kim; Kotb Abdelmohsen; Ashish Lal; Jennifer L Martindale; Xiaoling Yang; Myriam Gorospe
Journal:  Mol Cell Biol       Date:  2007-07-09       Impact factor: 4.272

Review 2.  ALS: a disease of motor neurons and their nonneuronal neighbors.

Authors:  Séverine Boillée; Christine Vande Velde; Don W Cleveland
Journal:  Neuron       Date:  2006-10-05       Impact factor: 17.173

3.  A conserved AU-rich element in the 3' untranslated region of bcl-2 mRNA is endowed with a destabilizing function that is involved in bcl-2 down-regulation during apoptosis.

Authors:  N Schiavone; P Rosini; A Quattrone; M Donnini; A Lapucci; L Citti; A Bevilacqua; A Nicolin; S Capaccioli
Journal:  FASEB J       Date:  2000-01       Impact factor: 5.191

4.  Bax and Bcl-2 interaction in a transgenic mouse model of familial amyotrophic lateral sclerosis.

Authors:  S Vukosavic; M Dubois-Dauphin; N Romero; S Przedborski
Journal:  J Neurochem       Date:  1999-12       Impact factor: 5.372

5.  Piracetam improves mitochondrial dysfunction following oxidative stress.

Authors:  Uta Keil; Isabel Scherping; Susanne Hauptmann; Katin Schuessel; Anne Eckert; Walter E Müller
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 6.  Molecular biology of amyotrophic lateral sclerosis: insights from genetics.

Authors:  Piera Pasinelli; Robert H Brown
Journal:  Nat Rev Neurosci       Date:  2006-09       Impact factor: 34.870

7.  HuR: post-transcriptional paths to malignancy.

Authors:  Isabel López de Silanes; Ashish Lal; Myriam Gorospe
Journal:  RNA Biol       Date:  2005-01-19       Impact factor: 4.652

8.  Mutant Cu/Zn-superoxide dismutase associated with amyotrophic lateral sclerosis destabilizes vascular endothelial growth factor mRNA and downregulates its expression.

Authors:  Liang Lu; Lei Zheng; Liliana Viera; Esther Suswam; Yanyan Li; Xuelin Li; Alvaro G Estévez; Peter H King
Journal:  J Neurosci       Date:  2007-07-25       Impact factor: 6.167

9.  Decrease of endogenous vascular endothelial growth factor may not affect glioma cell proliferation and invasion.

Authors:  Xin Hong; Feng Jiang; Steven N Kalkanis; Zheng Gang Zhang; Xuepeng Zhang; Xuguang Zheng; Tom Mikkelsen; Hao Jiang; Michael Chopp
Journal:  J Exp Ther Oncol       Date:  2007

10.  Mutant copper-zinc superoxide dismutase associated with amyotrophic lateral sclerosis binds to adenine/uridine-rich stability elements in the vascular endothelial growth factor 3'-untranslated region.

Authors:  Xuelin Li; Liang Lu; Donald J Bush; Xiaowen Zhang; Lei Zheng; Esther A Suswam; Peter H King
Journal:  J Neurochem       Date:  2009-02       Impact factor: 5.372

View more
  26 in total

1.  T-Cell Intracellular Antigens and Hu Antigen R Antagonistically Modulate Mitochondrial Activity and Dynamics by Regulating Optic Atrophy 1 Gene Expression.

Authors:  Isabel Carrascoso; José Alcalde; Carmen Sánchez-Jiménez; Paloma González-Sánchez; José M Izquierdo
Journal:  Mol Cell Biol       Date:  2017-08-11       Impact factor: 4.272

2.  The RNA-binding protein HuR promotes glioma growth and treatment resistance.

Authors:  Natalia Filippova; Xiuhua Yang; Yimin Wang; G Yancey Gillespie; Cathy Langford; Peter H King; Crystal Wheeler; L Burt Nabors
Journal:  Mol Cancer Res       Date:  2011-04-15       Impact factor: 5.852

Review 3.  Gene and protein therapies utilizing VEGF for ALS.

Authors:  Orion P Keifer; Deirdre M O'Connor; Nicholas M Boulis
Journal:  Pharmacol Ther       Date:  2013-10-29       Impact factor: 12.310

Review 4.  miRNAs at the interface of cellular stress and disease.

Authors:  Anna Emde; Eran Hornstein
Journal:  EMBO J       Date:  2014-05-27       Impact factor: 11.598

Review 5.  Cerebrovascular disorders: molecular insights and therapeutic opportunities.

Authors:  Erik Storkebaum; Annelies Quaegebeur; Miikka Vikkula; Peter Carmeliet
Journal:  Nat Neurosci       Date:  2011-10-26       Impact factor: 24.884

6.  Neovascularization, enhanced inflammatory response, and age-related cone dystrophy in the Nrl-/-Grk1-/- mouse retina.

Authors:  Rosanne M Yetemian; Bruce M Brown; Cheryl M Craft
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-08-04       Impact factor: 4.799

7.  Hu antigen R (HuR) is a positive regulator of the RNA-binding proteins TDP-43 and FUS/TLS: implications for amyotrophic lateral sclerosis.

Authors:  Liang Lu; Lei Zheng; Ying Si; Wenyi Luo; Gwendal Dujardin; Thaddaeus Kwan; Nicholas R Potochick; Sunnie R Thompson; David A Schneider; Peter H King
Journal:  J Biol Chem       Date:  2014-09-19       Impact factor: 5.157

8.  KSRP: a checkpoint for inflammatory cytokine production in astrocytes.

Authors:  Xuelin Li; Wei-Jye Lin; Ching-Yi Chen; Ying Si; Xiaowen Zhang; Liang Lu; Esther Suswam; Lei Zheng; Peter H King
Journal:  Glia       Date:  2012-07-28       Impact factor: 7.452

9.  Induction of VEGFA mRNA translation by CoCl2 mediated by HuR.

Authors:  Cecilia Osera; Jennifer L Martindale; Marialaura Amadio; Jiyoung Kim; Xiaoling Yang; Christopher A Moad; Fred E Indig; Stefano Govoni; Kotb Abdelmohsen; Myriam Gorospe; Alessia Pascale
Journal:  RNA Biol       Date:  2015-09-01       Impact factor: 4.652

10.  Neuron-Specific HuR-Deficient Mice Spontaneously Develop Motor Neuron Disease.

Authors:  Kevin Sun; Xiao Li; Xing Chen; Ying Bai; Gao Zhou; Olga N Kokiko-Cochran; Bruce Lamb; Thomas A Hamilton; Ching-Yi Lin; Yu-Shang Lee; Tomasz Herjan
Journal:  J Immunol       Date:  2018-05-14       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.